Rituximab in Mucous Membrane Pemphigoid: Current Evidence and Clinical Perspectives. (PubMed, Healthcare (Basel)) - Sep 27, 2026 - " Based on our experience, we support the early use of rituximab in high-risk patients with MMP. Prompt diagnosis and early, aggressive treatment in the inflammatory phase are essential to prevent scarring."
Journal • Conjunctivitis • Fibrosis • Gastrointestinal Disorder • Immunology • Ocular Infections • Ocular Inflammation • Ophthalmology
|
|
Calin Giurcaneanu; Cristina Popescu; Liliana Gabriela Popa; Marina Cozma; Olguta Anca Orzan; Selda Ali; Valeria Coviltir
|